248
Views
0
CrossRef citations to date
0
Altmetric
Review

Immunopathological and molecular basis of functional dyspepsia and current therapeutic approaches

, , & ORCID Icon
Pages 831-840 | Received 19 Jul 2018, Accepted 13 Sep 2018, Published online: 29 Sep 2018

References

  • Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016;150(6):1380–1392.
  • Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–1491.
  • Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257–1261.
  • Ford AC, Marwaha A, Sood R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64(7):1049–1057.
  • Tack J, Piessevaux H, Couli B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115(6):1346–1352.
  • Mak AD, Wu JC, Chan Y, et al. Dyspepsia is strongly associated with major depression and generalised anxiety disorder - a community study. Aliment Pharmacol Ther. 2012;36(8):800–810.
  • Talley NJ, Walker MM, Holtmann G. Functional dyspepsia. Curr Opin Gastroenterol. 2016;32(6):467–473.
  • Lacy BE, Talley NJ, Locke GR 3rd. et al. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012;36(1):3–15.
  • El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther. 2003;18(4):387–393.
  • Ochoa-Cortes F, Turco F, Linan-Rico A, et al. Enteric glial cells: a new frontier in neurogastroenterology and clinical target for inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22(2):433–449.
  • Ruhl A. Glial cells in the gut. Neurogastroenterol Motil. 2005;17(6):777–790.
  • Tominaga K, Fujikawa Y, Tanaka F, et al. Structural changes in gastric glial cells and delayed gastric emptying as responses to early life stress and acute adulthood stress in rats. Life Sci. 2016;148:254–259.
  • Lee HS, Kim DK, Kim YB, et al. Effect of acute stress on immune cell counts and the expression of tight junction proteins in the duodenal mucosa of rats. Gut Liver. 2013;7(2):190–196.
  • Cirillo C, Bessissow T, Desmet AS, et al. Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia. Am J Gastroenterol. 2015;110(8):1205–1215.
  • Tanaka F, Tominaga K, Fujikawa Y, et al. Concentration of glial cell line-derived neurotrophic factor positively correlates with symptoms in functional dyspepsia. Dig Dis Sci. 2016;61(12):3478–3485.
  • Wouters MM, Boeckxstaens GE. Neuroimmune mechanisms in functional bowel disorders. Neth J Med. 2011;69(2):55–61.
  • Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010;7(3):146–156.
  • Zuo L, Rothenberg ME. Gastrointestinal eosinophilia. Immunol Allergy Clin North Am. 2007;27(3):443–455.
  • Rothenberg ME, Cohen MB. An eosinophil hypothesis for functional dyspepsia. Clin Gastroenterol Hepatol. 2007;5(10):1147–1148.
  • Morgan RK, Costello RW, Durcan N, et al. Diverse effects of eosinophil cationic granule proteins on IMR-32 nerve cell signaling and survival. Am J Respir Cell Mol Biol. 2005;33(2):169–177.
  • Du L, Chen B, Kim JJ, et al. Micro-inflammation in functional dyspepsia: a systematic review and meta-analysis. Neurogastroenterol Motil. 2018;30(4):e13304.
  • Talley NJ, Walker MM, Aro P, et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol. 2007;5(10):1175–1183.
  • Du L, Shen J, Kim JJ, et al. Increased duodenal eosinophil degranulation in patients with functional dyspepsia: a prospective study. Sci Rep. 2016;6:34305.
  • Walker MM, Aggarwal KR, Shim LS, et al. Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an Australian cohort. J Gastroenterol Hepatol. 2014;29(3):474–479.
  • Futagami S, Shindo T, Kawagoe T, et al. Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious functional dyspepsia. Am J Gastroenterol. 2010;105(8):1835–1842.
  • Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014;63(2):262–271.
  • Pires GV, Souza HS, Elia CC, et al. Small bowel of patients with asthma and allergic rhinitis: absence of inflammation despite the presence of major cellular components of allergic inflammation. Allergy Asthma Proc. 2004;25(4):253–259.
  • Wallaert B, Desreumaux P, Copin MC, et al. Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med. 1995;182(6):1897–1904.
  • Powell N, Huntley B, Beech T, et al. Upper gastrointestinal symptoms and asthma: a manifestation of allergy? Gut. 2008;57(7):1026–1027.
  • Kindt S, Tertychnyy A, de Hertogh G, et al. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil. 2009;21(8):832–e56.
  • Li X, Chen H, Lu H, et al. The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia. Scand J Gastroenterol. 2010;45(5):573–581.
  • Matos NA, Silva JF, Matsui TC, et al. Mast cell tryptase induces eosinophil recruitment in the pleural cavity of mice via proteinase-activated receptor 2. Inflammation. 2013;36(6):1260–1267.
  • Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut. 2004;53(8):1096–1101.
  • Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136(6):1979–1988.
  • De Giorgio R, Barbara G. Is irritable bowel syndrome an inflammatory disorder? Curr Gastroenterol Rep. 2008;10(4):385–390.
  • Nwokediuko SC, Ijoma UN, Obienu O, et al. High degree of duodenal inflammation in Nigerians with functional dyspepsia. Clin Exp Gastroenterol. 2013;7:7–12.
  • Tack J, Demedts I, Dehondt G, et al. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology. 2002;122(7):1738–1747.
  • Mearin F, Perez-Oliveras M, Perello A, et al. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology. 2005;129(1):98–104.
  • Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2005 Jan 25;(1):CD002096.
  • Zhao B, Zhao J, Cheng WF, et al. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol. 2014;48(3):241–247.
  • Wyatt JI, Rathbone BJ, Sobala GM, et al. Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol. 1990;43(12):981–986.
  • Catalano F, Branciforte G, Brogna A, et al. Helicobacter pylori-positive functional dyspepsia in elderly patients: comparison of two treatments. Dig Dis Sci. 1999;44(5):863–867.
  • Naz F, Malik S, Afzal S, et al. Frequency of seropositivity of Helicobacter pylori in patients presenting with dyspepsia. J Ayub Med Coll Abbottabad. 2013;25(3–4):50–54.
  • Taddesse G, Habteselassie A, Desta K, et al. Association of dyspepsia symptoms and Helicobacter pylori infections in private higher clinic, Addis Ababa, Ethiopia. Ethiop Med J. 2011;49(2):109–116.
  • Ayana SM, Swai B, Maro VP, et al. Upper gastrointestinal endoscopic findings and prevalence of Helicobacter pylori infection among adult patients with dyspepsia in northern Tanzania. Tanzan J Health Res. 2014;16(1):16–22.
  • Mirbagheri SA, Khajavirad N, Rakhshani N, et al. Impact of Helicobacter pylori infection and microscopic duodenal histopathological changes on clinical symptoms of patients with functional dyspepsia. Dig Dis Sci. 2012;57(4):967–972.
  • Sugano K, Tak J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–136748.
  • Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303(7):G775–785.
  • Williams AM, Probert CS, Stepankova R, et al. Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse. Immunology. 2006;119(4):470–478.
  • Verdu EF, Bercik P, Verma-Gandhu M, et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut. 2006;55(2):182–190.
  • Hrncir T, Stepankova R, Kozakova H, et al. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol. 2008;9:65.
  • Rajilic-Stojanovic M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141(5):1792–1801.
  • Nakae H, Tsuda A, Matsuoka T, et al. Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt. BMJ Open Gastroenterol. 2016;3(1):e000109.
  • Igarashi M, Nakae H, Matsuoka T, et al. Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia. BMJ Open Gastroenterol. 2017;4(1):e000144.
  • Takagi A, Yanagi H, Ozawa H, et al. Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-associated dyspepsia: a multicenter randomized double-blind controlled trial. Gastroenterol Res Pract. 2016;2016:7490452.
  • Fukui H, Xu X, Miwa H. Role of gut microbiota-gut hormone axis in the pathophysiology of functional gastrointestinal disorders. J Neurogastroenterol Motil. 2018;24(3):367–386.
  • Park MI. Is there enough evidence for the association of GNbeta3 C825T polymorphism with functional dyspepsia and irritable bowel syndrome? J Neurogastroenterol Motil. 2012;18(3):348–349.
  • Kim HG, Lee KJ, Lim SG, et al. G-protein beta3 subunit C825T polymorphism in patients with overlap syndrome of functional dyspepsia and irritable bowel syndrome. J Neurogastroenterol Motil. 2012;18(2):205–210.
  • Lindemann M, Virchow S, Ramann F, et al. The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett. 2001;495(1–2):82–86.
  • Holtmann G, Siffert W, Haag S, et al. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology. 2004;126(4):971–979.
  • Tahara T, Arisawa T, Shibata T, et al. Homozygous 825T allele of the GNB3 protein influences the susceptibility of Japanese to dyspepsia. Dig Dis Sci. 2008;53(3):642–646.
  • Choi YJ, Kim N, Kim J, et al. Upregulation of vanilloid receptor-1 in functional dyspepsia with or without helicobacter pylori infection. Medicine (Baltimore). 2016;95(19):e3410.
  • Tahara T, Shibata T, Yamashita H, et al. The role of RANTES promoter polymorphism in functional dyspepsia. J Clin Biochem Nutr. 2009;45(2):235–240.
  • Talley NJ, Van Zanten SV, Saez LR, et al. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia. Aliment Pharmacol Ther. 2001;15(4):525–537.
  • Mujakovic S, Ter Linde JJ, de Wit NJ, et al. Serotonin receptor 3A polymorphism c.-42C > T is associated with severe dyspepsia. BMC Med Genet. 2011;12:140.
  • Feinle C, Meier O, Otto B, et al. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut. 2001;48(3):347–355.
  • Tahara T, Arisawa T, Shibata T, et al. 779 TC of CCK-1 intron 1 is associated with postprandial syndrome (PDS) in Japanese male subjects. Hepatogastroenterology. 2009;56(93):1245–1248.
  • Singh R, Mittal B, Ghoshal UC. Functional dyspepsia is associated with GNbeta3 C825T and CCK-AR T/C polymorphism. Eur J Gastroenterol Hepatol. 2016;28(2):226–232.
  • Kuiken SD, Vergeer M, Heisterkamp SH, et al. Role of nitric oxide in gastric motor and sensory functions in healthy subjects. Gut. 2002;51(2):212–218.
  • Park JM, Baeg MK, Lim CH, et al. Nitric oxide synthase gene polymorphisms in functional dyspepsia. Dig Dis Sci. 2014;59(1):72–77.
  • Arisawa T, Tahara T, Shibata T, et al. Genetic polymorphisms of cyclooxygenase-1 (COX-1) are associated with functional dyspepsia in Japanese women. J Womens Health (Larchmt). 2008;17(6):1039–1043.
  • Arisawa T, Tahara T, Shibata T, et al. Genetic polymorphisms of molecules associated with inflammation and immune response in Japanese subjects with functional dyspepsia. Int J Mol Med. 2007;20(5):717–723.
  • Tahara T, Arisawa T, Shibata T, et al. COMT gene val158met polymorphism in patients with dyspeptic symptoms. Hepatogastroenterology. 2008;55(84):979–982.
  • Tahara T, Arisawa T, Shibata T, et al. A genetic variant of the CD14 C-159T in patients with functional dyspepsia (FD) in Japanese subjects. J Clin Biochem Nutr. 2008;42(2):104–110.
  • Tahara T, Shibata T, Okubo M, et al. Change in DNA methylation patterns of SLC6A4 gene in the gastric mucosa in functional dyspepsia. PLoS One. 2014;9(8):e105565.
  • van Lelyveld N, Linde JT, Schipper M, et al. Candidate genotypes associated with functional dyspepsia. Neurogastroenterol Motil. 2008;20(7):767–773.
  • Gathaiya N, Locke GR 3rd, Camilleri M, et al. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009;21(9):922–e69.
  • Wang WH, Huang JQ, Zheng GF, et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol. 2007;5(2):178–185.
  • Abraham NS, Moayyedi P, Daniels B, et al. Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia. Aliment Pharmacol Ther. 2004;19(6):631–641.
  • Kusunoki H, Haruma K, Manabe N, et al. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography. Neurogastroenterol Motil. 2012;24(6):540–545, e250-1.
  • Orive M, Barrio I, Orive VM, et al. A randomized controlled trial of a 10 week group psychotherapeutic treatment added to standard medical treatment in patients with functional dyspepsia. J Psychosom Res. 2015;78(6):563–568.
  • Tack J, Janssen P, Masaoka T, et al. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol. 2012;10(11):1239–1245.
  • Tan VP, Cheung TK, Wong WM, et al. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol. 2012;18(42):6127–6133.
  • Jiang SM, Jia L, Liu J, et al. Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients with weight loss. World J Gastroenterol. 2016;22(22):5260–5266.
  • Friesen CA, Kearns GL, Andre L, et al. Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr. 2004;38(3):343–351.
  • Friesen CA, Neilan NA, Schurman JV, et al. Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics. BMC Gastroenterol. 2009;9:32.
  • Friesen CA, Sandridge L, Andre L, et al. Mucosal eosinophilia and response to H1/H2 antagonist and cromolyn therapy in pediatric dyspepsia. Clin Pediatr (Phila). 2006;45(2):143–147.
  • Friesen CA, Schurman JV, Colombo JM, et al. Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia. World J Gastrointest Pharmacol Ther. 2013;4(4):86–96.
  • Choung RS, Locke GR 3rd, Schleck CD, et al. Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil. 2012;24(3):229–234, e106.
  • Tack J, Caenepeel P, Arts J, et al. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut. 2005;54(10):1370–1376.
  • Tominaga K, Tsumoto C, Ataka S, et al. Regional brain disorders of serotonin neurotransmission are associated with functional dyspepsia. Life Sci. 2015;137:150–157.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.